The fourth summit on hereditary blood disorders kicks off in Saudi Arabia: Prospects for gene therapy
In a move reflecting the Kingdom of Saudi Arabia's commitment to developing its healthcare system and enhancing its position as a leading medical center regionally and internationally, His Excellency the Deputy Minister of Health, Professor Mohammed bin Aam, inaugurated the fourth edition of the "Hereditary Blood Disorders Summit" under the patronage of His Excellency the Minister of Health. This summit is a prominent scientific event that brings together leading experts and decision-makers to discuss the latest developments in the diagnosis and treatment of genetic diseases.
The summit's importance and strategic context:
This summit is of exceptional importance given the prevalence of hereditary blood disorders, such as sickle cell anemia and thalassemia, in some regions of the Kingdom and the Middle East. These efforts align with the objectives of "Saudi Vision 2030" and the Health Sector Transformation Program, which prioritizes prevention and public health promotion. Through these events, the Ministry of Health aims to transition from traditional care to advanced care models based on precision medicine and innovative genetic solutions, thereby contributing to reducing the burden of disease on future generations.
An intensive scientific program and global participation
mark the summit's events, which will take place from February 5th to 7th, offering healthcare practitioners the opportunity to earn 18 accredited Continuing Medical Education (CME) hours. The scientific program focuses on vital topics including early diagnosis, advancements in gene therapy (a revolution in modern medicine), and strategies for patient management and improving quality of life. The summit boasts significant international momentum with the active participation of prestigious global organizations such as the World Federation of Hemophilia and the Thalassemia International Federation, along with prominent speakers from North America and Europe, and regional experts from the Gulf Cooperation Council (Kuwait, Oman, and the UAE). This fosters the exchange of expertise, knowledge transfer, and the localization of modern treatment technologies.
Patient empowerment and community partnership:
The summit is not limited to the medical and technical aspects, but also places great emphasis on the humanitarian and social dimensions by highlighting the role of patient associations across the Kingdom. The summit features specialized sessions aimed at empowering patients and their families, raising health awareness, and discussing the psychological, physical, and social aspects of illness. This initiative underscores the importance of partnership between the healthcare and non-profit sectors to ensure the provision of comprehensive and sustainable care that guarantees a dignified life for patients.
In conclusion, the fourth edition of the Genetic Blood Diseases Summit represents an integrated collaborative platform aimed at uniting efforts among all stakeholders, to ensure a brighter and more sustainable health future, and to consolidate the Kingdom’s leadership in the field of advanced genetic research and treatments.
